Q-linea Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Stuart Gander

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	less than a year
CEO ownership	n/a
Management average tenure	3.5yrs
Board average tenure	2.6yrs

Recent management updates

Recent updates

CEO

Stuart Gander (46 yo)

less than a year

Tenure

Mr. Stuart Gander is Chief Executive Officer at Q-linea AB (publ) since January 22, 2024. He served as Senior Vice President of Marketing and Channel Sales of SLMP, LLC from January 2022 until 2024. He has...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Stuart Gander	Chief Executive Officer	less than a year	no data	no data
Christer Samuelsson	CFO & IR	1.2yrs	no data	0.043% SEK 174.0k
Henrik Jacobson	Chief Operating Officer	2.5yrs	no data	0.0092% SEK 37.6k
Ulrika Stolpe	HR Manager	5.5yrs	no data	0.0029% SEK 12.0k
Tiziana Di Martino	Chief Medical Officer	5yrs	no data	no data
Thomas Fritz	Chief Commercial Officer	4.8yrs	no data	0.050% SEK 203.6k
Anders Ljunggren	Managing Director	less than a year	no data	0.011% SEK 42.8k
Victoria Lerneryd	Manager of QA/RA	4.5yrs	no data	0.0065% SEK 26.4k

3.5yrs

Average Tenure

51.5yo

Average Age

Experienced Management: QLINEA's management team is considered experienced (3.5 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Erika Eriksson	Chairperson	12.5yrs	no data	0.17% SEK 692.5k
Hans Johansson	Independent Director	6.5yrs	SEK 222.00k	0.020% SEK 81.9k
Jonas Jarvius	Director	less than a year	SEK 3.32m	0.40% SEK 1.6m
Karin Fischer	Independent Director	1.1yrs	SEK 135.00k	no data
Mario Gualano	Independent Deputy Chairperson	4.2yrs	SEK 279.00k	no data
Finn Albrechtsen	Independent Director	1.1yrs	SEK 122.00k	0.086% SEK 348.0k

2.6yrs

Average Tenure

56yo

Average Age

Experienced Board: QLINEA's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.

Q-linea Management

Management criteria checks 1/4

Key information

Recent management updates

Q-linea AB (publ) Approves the Election of Jonas Jarvius as Members of the Board of Directors

Q-Linea AB Appoints Anders Ljunggren as Managing Director, Effective 1 March 2024

Q-linea AB (publ) Announces CEO Changes

Q-Linea AB (Publ) Announces Jonas Jarvius to Step Down as CEO Before Summer 2024

Insufficient new directors

CFO & Investor Relations Officer recently bought kr143k worth of stock

Recent updates

Consensus revenue estimates fall by 42%

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Q-linea AB (publ) to Report Q1, 2025 Results on May 03, 2025

Q-linea AB (publ) Approves the Election of Jonas Jarvius as Members of the Board of Directors

Consensus revenue estimates increase by 49%

First quarter 2024 earnings released: kr0.48 loss per share (vs kr2.10 loss in 1Q 2023)

Full year 2023 earnings: EPS and revenues miss analyst expectations

Consensus revenue estimates increase by 24%, EPS downgraded

New minor risk - Profitability

No longer forecast to breakeven

Full year 2023 earnings: EPS and revenues miss analyst expectations

Q-Linea AB Appoints Anders Ljunggren as Managing Director, Effective 1 March 2024

Q-linea AB (publ) Announces CEO Changes

Q-linea AB (publ) to Report First Half, 2024 Results on Jul 11, 2024

Q-linea AB (publ) to Report Fiscal Year 2023 Results on Feb 27, 2024

Here's Why Q-linea (STO:QLINEA) Must Use Its Cash Wisely

Forecast to breakeven in 2026

Consensus revenue estimates decrease by 27%

Price target decreased by 13% to kr10.00

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Q-Linea AB (Publ) Announces Jonas Jarvius to Step Down as CEO Before Summer 2024

Q-linea AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 262.885275 million.

New major risk - Share price stability

Consensus revenue estimates decrease by 40%, EPS upgraded

Q-linea AB (publ) Completes its 510(k) Application for US Market Approval

Second quarter 2023 earnings released: kr2.23 loss per share (vs kr2.53 loss in 2Q 2022)

Q-linea AB (publ) Announces First Patient Enrolls in Lifetimes

Consensus revenue estimates increase by 40%, EPS downgraded

Insufficient new directors

Full year 2022 earnings: EPS and revenues miss analyst expectations

CFO & Investor Relations Officer recently bought kr143k worth of stock

Full year 2022 earnings released: kr9.20 loss per share (vs kr8.19 loss in FY 2021)

Q-linea AB (publ) Announces CFO Changes, Effective May 1, 2023

Q-linea AB (publ) Prepare to Start Additional Testing for US 510(K) Application

Q-Linea Participates in Comparative Rapid AST Study

VP & Research Director recently bought kr241k worth of stock

Consensus revenue estimates fall by 21%

Q-linea AB (publ) to Report Q1, 2023 Results on May 04, 2023

Third quarter 2022 earnings released: kr2.03 loss per share (vs kr1.68 loss in 3Q 2021)

Consensus revenue estimates fall by 34%

Second quarter 2022 earnings released: kr2.53 loss per share (vs kr2.47 loss in 2Q 2021)

Consensus revenue estimates fall by 82%

Will Q-linea (STO:QLINEA) Spend Its Cash Wisely?

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Now 22% undervalued after recent price drop

Price target decreased to kr165

Q-linea AB (publ) Announces Marcus Storch Not Available for Re-Election as Member of Board of Directors

Full year 2021 earnings: EPS and revenues miss analyst expectations

CEO & President recently bought kr480k worth of stock

Insufficient new directors

Now 22% undervalued after recent price drop

Price target decreased to kr165

Forecast breakeven date pushed back to 2024

Full year 2021 earnings: EPS and revenues miss analyst expectations

Q-linea (STO:QLINEA) Is In A Good Position To Deliver On Growth Plans

Forecast to breakeven in 2023

Third quarter 2021 earnings released: kr1.68 loss per share (vs kr1.80 loss in 3Q 2020)

Forecast to breakeven in 2023

Second quarter 2021 earnings released: kr2.47 loss per share (vs kr2.37 loss in 2Q 2020)

CEO & President recently sold kr14m worth of stock

Q-linea AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 301.4 million.

Q-linea AB (publ) Initiates US 510(k) Clinical Study for ASTar

Consensus forecasts updated

First quarter 2021 earnings released: kr2.34 loss per share (vs kr2.44 loss in 1Q 2020)

Full year 2020 earnings released: kr8.64 loss per share (vs kr7.74 loss in FY 2019)

Price target increased to kr185

Q-linea AB (publ) Receives First Order on ASTar

Full year 2020 earnings released: kr8.64 loss per share (vs kr7.74 loss in FY 2019)

Revenue beats expectations